News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Dr. Reddy’s Laboratories Ltd.'s to Release Q3 FY13 Results on February 14, 2013
February 6, 2013
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Third Quarter and Nine months ended December 31, 2012 on Thursday, February 14, 2013 after the Board Meeting. The results will be available on the Company’s website www.drreddys.com.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Asia
MORE ON THIS TOPIC
Mergers & acquisitions
Merck To Buy Terns, ‘Unprecedented’ Leukemia Drug for $6.7B as Keytruda Cliff Looms
March 25, 2026
·
3 min read
·
Tristan Manalac
Funding
RA Capital Looks to China for Next Startup To Put on SPAC Track to Nasdaq
March 25, 2026
·
2 min read
·
Tristan Manalac
Podcast
Gilead’s Ouro Buy, J&J/Protagonist’s Approval, Aurinia’s Revamp, ACIP Confusion, More
March 25, 2026
·
1 min read
·
Heather McKenzie
Manufacturing
Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca
March 24, 2026
·
2 min read
·
Nick Paul Taylor
